Jaejin An to Atrial Fibrillation
This is a "connection" page, showing publications Jaejin An has written about Atrial Fibrillation.
Connection Strength
3.433
-
Race, Ethnicity, and Language Concordance Between Patients and Physicians and Atrial Fibrillation DOAC Treatment. JAMA Netw Open. 2026 Sep 01; 9(9):e2629363.
Score: 0.847
-
Validation of electronic health record-based International Society on Thrombosis and Haemostasis bleeding algorithms in a US health system. Res Pract Thromb Haemost. 2026 May; 10(4):106616.
Score: 0.827
-
Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk. Clin Ther. 2023 07; 45(7):e151-e158.
Score: 0.679
-
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System. J Manag Care Spec Pharm. 2017 Jun; 23(6):700-712.
Score: 0.446
-
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc. 2015 Jul 17; 4(7).
Score: 0.392
-
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves. Am J Cardiol. 2021 05 01; 146:22-28.
Score: 0.144
-
Medication Extraction from Electronic Clinical Notes in an Integrated Health System: A Study on Aspirin Use in Patients with Nonvalvular Atrial Fibrillation. Clin Ther. 2015 Sep; 37(9):2048-2058.e2.
Score: 0.098